Surmodics Reports First Quarter Fiscal 2019 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Wall St futures fall as yields and oil rebound; Fed minutes in focus
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Musk rules out TSMC role in Terafab operations; Intel gains
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- HubSpot to cut 7% of workforce in restructuring plan
- Emera and Canadian Utilities agree to merge in $72B all-share deal
- Caribou Biosciences to halt CAR-T programs, explore sale
- Stryker names Spencer Stiles as CEO, Lobo moves to chair
- Francis Halzen wins Nobel physics prize for Antarctic 'ghost particle' hunt
SurModics (SRDX) PT Lowered to $69 at Needham & Company
January 31, 2019 8:26 AM ESTNeedham & Company analyst Mike Matson lowered the price target on SurModics (NASDAQ: SRDX) to $69.00 (from $74.00) while maintaining a Buy rating.
Matson commented, "RDX beat consensus F1Q19 revenue and EPS estimates. Management raised the lower end of its FY19 revenue guidance and narrowed... More
SurModics (SRDX) Reports Q1 EPS of $0.12, Revenues Beat; Raises FY19 EPS/Revenue Mid-Point Guidance Above Consensus
January 30, 2019 4:31 PM ESTSurModics (NASDAQ: SRDX) reported Q1 EPS of $0.12, versus $0.10 reported last year. Revenue for the quarter came in at $22.2 million versus the consensus estimate of $20.18 million.
Revenue of $22.2 million, an increase of 31% year-over-yearGAAP EPS of $0.09, non-GAAP EPS of $0.12Updating fiscal 2019... More


